Education

Health Column

February 16, 1994 1 min read
  • Save to favorites
  • Print

A vaccine for chicken pox appears to be nearing federal approval, now that it has received a conditional go-ahead from an advisory committee of the Food and Drug Administration.

The F.D.A. panel, made up of outside experts, found that the vaccine developed by Merck & Company, a New Jersey-based pharmaceutical firm, is safe and effective for the prevention of chicken pox.

The panel said several issues must be resolved before the drug is approved, however.

Committee members said it remained to be seen whether the vaccine provides long-term immunity; whether it would result in more cases of adult chicken pox, which can be more serious; whether it would affect the development of shingles as a result of the chicken-pox virus; and how the vaccine should be administered.

In separate research on chicken-pox vaccinations, an article published in the Feb. 2 issue of the Journal of the American Medical Association, said a routine vaccination program for children would save more than $5 for every $1 spent on immunizations.

Researchers from the University of California at San Francisco, the U.S. Centers for Disease Control and Prevention, and the Emory University School of Public Health in Atlanta found that an immunization program would result in substantial savings from a societal perspective, which takes into account work-loss costs as well as medical costs.

From a medical-cost perspective, however, such a program would lose money, the researchers found.

The National Academy of Sciences has released a report on reducing risks for mental illness.

Compiled by a committee of the Institute of Medicine, an independent research group chartered by the N.A.S., the book-length report defines prevention initiatives, and recommends that the federal government, state governments, and related institutions take up an “enhanced’’ research agenda to prevent mental illness, including well-researched preventive interventions.

Among other interventions, the report describes several school-based programs.

Copies of “Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research’’ are available for $49.95 each, plus $4 shipping and handling, from the National Academy Press by calling (800) 624-6242; in Washington, (202) 334-3313.
--SARA SKLAROFF

Events

Jobs Virtual Career Fair for Teachers and K-12 Staff
Find teaching jobs and other jobs in K-12 education at the EdWeek Top School Jobs virtual career fair.
Ed-Tech Policy Webinar Artificial Intelligence in Practice: Building a Roadmap for AI Use in Schools
AI in education: game-changer or classroom chaos? Join our webinar & learn how to navigate this evolving tech responsibly.
Education Webinar Developing and Executing Impactful Research Campaigns to Fuel Your Ed Marketing Strategy 
Develop impactful research campaigns to fuel your marketing. Join the EdWeek Research Center for a webinar with actionable take-aways for companies who sell to K-12 districts.

EdWeek Top School Jobs

Teacher Jobs
Search over ten thousand teaching jobs nationwide — elementary, middle, high school and more.
View Jobs
Principal Jobs
Find hundreds of jobs for principals, assistant principals, and other school leadership roles.
View Jobs
Administrator Jobs
Over a thousand district-level jobs: superintendents, directors, more.
View Jobs
Support Staff Jobs
Search thousands of jobs, from paraprofessionals to counselors and more.
View Jobs

Read Next

Education Briefly Stated: February 21, 2024
Here's a look at some recent Education Week articles you may have missed.
8 min read
Education Briefly Stated: February 7, 2024
Here's a look at some recent Education Week articles you may have missed.
8 min read
Education Briefly Stated: January 31, 2024
Here's a look at some recent Education Week articles you may have missed.
9 min read
Education Briefly Stated: January 17, 2024
Here's a look at some recent Education Week articles you may have missed.
9 min read